Literature DB >> 29735508

Carbimazole-induced eosinophilic pleural effusion.

Chris Ferguson1, Claire Bradley1, Joe Kidney1.   

Abstract

We report the case of a 41-year-old woman who presented with a unilateral exudative effusion with prominent eosinophils on pleural cytology. Carbimazole had been started 4 weeks prior to presentation. No immediate cause was identified on imaging or laboratory testing. The effusion persisted at 2-month follow-up. Further investigation at this time, including autoimmune serology was negative. At 2-month follow-up, the effusion was loculated on ultrasound imaging and had a low fluid pH on diagnostic aspiration, in keeping with an empyema. The patient received treatment for pleural empyema, including antibiotics, intercostal drain insertion and video-assisted thoracoscopic pleural biopsy. Carbimazole was stopped, and following treatment for the empyema, the effusion did not reaccumulate.This case illustrates the diagnostic difficulties that pleural effusions may present. It demonstrates that drug reactions should be considered in the differential diagnosis following thorough investigation for other potential causes and also describes the complications that may occur. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  respiratory medicine; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2018        PMID: 29735508      PMCID: PMC5950692          DOI: 10.1136/bcr-2018-224701

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  A LUPUS-LIKE SYNDROME FOLLOWING PROPYLTHIOURACIL ADMINISTRATION.

Authors:  M M BEST; C H DUNCAN
Journal:  J Ky Med Assoc       Date:  1964-01

2.  Drug-induced eosinophilic pleural effusion.

Authors:  R Krenke; R W Light
Journal:  Eur Respir Rev       Date:  2011-12

3.  Propylthiouracil-associated eosinophilic pleural effusion: a case report.

Authors:  Nazan Sen; Hilal Ermis; Meltem Karatasli; Mehmet Ali Habesoglu; Fusun Oner Eyuboglu
Journal:  Respiration       Date:  2007-01-18       Impact factor: 3.580

4.  Incidence and aetiology of eosinophilic pleural effusion.

Authors:  R Krenke; J Nasilowski; P Korczynski; K Gorska; T Przybylowski; R Chazan; R W Light
Journal:  Eur Respir J       Date:  2009-04-22       Impact factor: 16.671

5.  Eosinophilic pleuritis due to propylthiouracil.

Authors:  K L Middleton; R Santella; J I Couser
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

6.  Vasculitis, pulmonary cavitation, and anemia during antithyroid drug therapy.

Authors:  F G Cassorla; D N Finegold; J S Parks; A Tenore; H Thawerani; L Baker
Journal:  Am J Dis Child       Date:  1983-02

7.  Carbimazole-induced exudative pleural effusions.

Authors:  Carol D Cardona Attard; Mark Gruppetta; Josanne Vassallo; Sandro Vella
Journal:  BMJ Case Rep       Date:  2016-04-04

8.  Methimazole associated eosinophilic pleural effusion: a case report.

Authors:  Pedro Gaspar-da-Costa; Filipa Duarte Silva; Júlia Henriques; Sónia do Vale; Sandra Braz; João Meneses Santos; Rui M M Victorino
Journal:  BMC Pharmacol Toxicol       Date:  2017-03-21       Impact factor: 2.483

9.  Carbimazole induced pleural effusion: a case report.

Authors:  Gautam Das; Stephen E R S Stanaway; Liz Brohan
Journal:  Case Rep Endocrinol       Date:  2012-03-29

10.  Propylthiouracil-induced lupus-like or vasculitis syndrome.

Authors:  Cuneyt Tetikkurt; Mehmet Yuruyen; Seza Tetikkurt; Nihal Bayar; Imran Ozdemir
Journal:  Multidiscip Respir Med       Date:  2012-07-17
View more
  1 in total

1.  Mesalamine-induced eosinophilic pleural effusion.

Authors:  Abdullah Al-Abcha; Fazal Raziq; Shouq Kherallah; Ahmad Alratroot
Journal:  BMJ Case Rep       Date:  2020-04-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.